Research advances in extrahepatic diseases associated with nonalcoholic fatty liver disease
DOI:10.3969/j.issn.1001-5256.2021.09.043
- VernacularTitle:非酒精性脂肪性肝病相关肝外疾病的研究进展
- Author:
Luying ZHU
1
;
Yuchen LI
;
Lihua DENG
;
Jingtong WANG
Author Information
1. Department of Geriatrics, Peking University People’s Hospital & The Second Clinical Medical College of Peking University, Beijing 100044, China
- Publication Type:Research Article
- Keywords:
Non-alcoholic Fatty Liver Disease;
Metabolic Syndrome X;
Cardiovascular Diseases;
Endocrine System Diseases;
Kidney Diseases;
Skin Diseases
- From:
Journal of Clinical Hepatology
2021;37(9):2215-2219.
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver diseases worldwide and covers a series of pathological manifestations from hepatic steatosis to inflammation, fibrosis, and even liver cirrhosis. NAFLD is associated with a wide range of extrahepatic diseases, including metabolic syndrome, cardiovascular disease, chronic kidney disease, endocrine diseases, obstructive sleep apnea-hypopnea syndrome, psoriasis, and skeleton-muscle diseases. The major causes of death in patients with NAFLD include cardiovascular disease, malignancies, and liver-related complications, suggesting that extrahepatic diseases associated with NAFLD should be taken seriously by clinicians. This article reviews the research advances in extrahepatic diseases associated with NAFLD, so as to provide ideas for clinical assessment and treatment.
